Header Logo

Connection

MAHBOOB ALAM to Treatment Outcome

Back to Details
This is a "connection" page, showing publications MAHBOOB ALAM has written about Treatment Outcome.
MAHBOOB ALAM
Connection Strength
1.331
Treatment Outcome
  1. Drug-Coated Balloon Failure Following Femoro-Popliteal Intervention: Where to Draw the Line? J Am Coll Cardiol. 2022 09 27; 80(13):1251-1253.
    View in: PubMed
    Score: 0.067
  2. Meta-Analysis Comparing Distal Radial Versus Traditional Radial Percutaneous Coronary Intervention or Angiography. Am J Cardiol. 2022 05 01; 170:31-39.
    View in: PubMed
    Score: 0.064
  3. Association of Body Mass Index With Outcomes in Patients Undergoing Percutaneous Left Atrial Appendage Closure With the Watchman Device. Curr Probl Cardiol. 2022 12; 47(12):101009.
    View in: PubMed
    Score: 0.063
  4. Comparative analysis of revascularization with percutaneous coronary intervention versus coronary artery bypass surgery for patients with end-stage renal disease: a nationwide inpatient sample database. Expert Rev Cardiovasc Ther. 2021 Aug; 19(8):763-768.
    View in: PubMed
    Score: 0.062
  5. Predictors of In-Hospital Mortality in Patients With End-Stage Renal Disease Undergoing Transcatheter Aortic Valve Replacement: A Nationwide Inpatient Sample Database Analysis. Cardiovasc Revasc Med. 2022 01; 34:63-68.
    View in: PubMed
    Score: 0.060
  6. Percutaneous coronary intervention in patients with cardiac allograft vasculopathy: a Nationwide Inpatient Sample (NIS) database analysis. Expert Rev Cardiovasc Ther. 2021 Mar; 19(3):269-276.
    View in: PubMed
    Score: 0.060
  7. Prescription Patterns of Clopidogrel, Prasugrel, and Ticagrelor After Percutaneous Coronary Intervention With Stent Implantation (from the NCDR PINNACLE Registry). Am J Cardiol. 2019 12 15; 124(12):1807-1812.
    View in: PubMed
    Score: 0.054
  8. Upsloping ST depression: Is it acute ischemia? Ann Noninvasive Electrocardiol. 2019 05; 24(3):e12607.
    View in: PubMed
    Score: 0.051
  9. Meta-Analysis of Comparison of 5-Year Outcomes of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Unprotected Left Main Coronary Artery in the Era of Drug-eluting Stents. Am J Cardiol. 2017 Nov 01; 120(9):1514-1520.
    View in: PubMed
    Score: 0.047
  10. Comparison by meta-analysis of percutaneous coronary intervention versus coronary artery bypass grafting in patients with a mean age of =70 years. Am J Cardiol. 2013 Sep 01; 112(5):615-22.
    View in: PubMed
    Score: 0.035
  11. Percutaneous coronary intervention vs. coronary artery bypass graft surgery for unprotected left main coronary artery disease in the drug-eluting stents era--an aggregate data meta-analysis of 11,148 patients. Circ J. 2013; 77(2):372-82.
    View in: PubMed
    Score: 0.034
  12. Clinical outcomes of percutaneous interventions in saphenous vein grafts using drug-eluting stents compared to bare-metal stents: a comprehensive meta-analysisof all randomized clinical trials. Clin Cardiol. 2012 May; 35(5):291-6.
    View in: PubMed
    Score: 0.032
  13. Long-term clinical outcomes after percutaneous coronary intervention for unprotected left main coronary artery in heart transplant patients with cardiac allograft vasculopathy. Int J Cardiol. 2012 Apr 05; 156(1):101-4.
    View in: PubMed
    Score: 0.032
  14. Isolated coronary artery bypass grafting in obese individuals: a propensity matched analysis of outcomes. Circ J. 2011; 75(6):1378-85.
    View in: PubMed
    Score: 0.030
  15. Intravascular Imaging-Guided Versus Angiography-Guided Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction in the United States. Catheter Cardiovasc Interv. 2025 03; 105(4):745-751.
    View in: PubMed
    Score: 0.020
  16. Meta-analysis of longitudinal comparison of transcatheter versus surgical aortic valve replacement in patients at low to intermediate surgical risk. Int J Surg. 2024 Dec 01; 110(12):8097-8106.
    View in: PubMed
    Score: 0.019
  17. Trends in Transcatheter Versus Surgical Aortic Valve Replacement Outcomes in Patients With Low-Surgical Risk: A Systematic Review and Meta-Analysis of Randomized Trials. J Am Heart Assoc. 2024 Nov 05; 13(21):e036179.
    View in: PubMed
    Score: 0.019
  18. Meta-Analysis Comparing Oral Anticoagulant Monotherapy Versus Dual Antithrombotic Therapy in Patients With Atrial Fibrillation and Stable Coronary Artery Disease. Clin Cardiol. 2024 Oct; 47(10):e70026.
    View in: PubMed
    Score: 0.019
  19. Comparative and combination study of simvastatin alone and in combination with Beta vulgaris in hyperlipidemia patients. Pak J Pharm Sci. 2024 Sep; 37(5):1033-1041.
    View in: PubMed
    Score: 0.019
  20. Cerebral embolic protection for stroke prevention during transcatheter aortic valve replacement. Expert Rev Cardiovasc Ther. 2024 Aug; 22(8):409-420.
    View in: PubMed
    Score: 0.019
  21. The Current State of Coronary Revascularization: Coronary Artery Bypass Graft Surgery Versus Percutaneous Coronary Interventions. Curr Cardiol Rep. 2024 Sep; 26(9):919-933.
    View in: PubMed
    Score: 0.019
  22. National Trends, Mortality and Outcomes in Intravascular Imaging-Guided Versus Angiography-Guided Percutaneous Coronary Intervention in the United States. Crit Pathw Cardiol. 2024 Dec 01; 23(4):202-206.
    View in: PubMed
    Score: 0.019
  23. Trends in Transcatheter Aortic Valve Implantation Utilization, Outcomes, and Healthcare Resource Use in Patients With Liver Cirrhosis: A Decade of Insights (2011-2020). Crit Pathw Cardiol. 2024 Sep 01; 23(3):166-173.
    View in: PubMed
    Score: 0.019
  24. Cardiovascular Outcomes of Transcatheter Aortic Valve Implantation in Patients With Chronic Kidney Disease in Octogenarian Population. Am J Cardiol. 2024 01 15; 211:163-171.
    View in: PubMed
    Score: 0.018
  25. In-hospital complications after MitraClip in patients with heart failure and preserved versus reduced ejection fraction in the United States. Cardiovasc Revasc Med. 2024 May; 62:34-39.
    View in: PubMed
    Score: 0.018
  26. Cardiovascular Outcomes of Transulnar Versus Transradial Percutaneous Coronary Angiography and Intervention: A Regression Matched Meta-Analysis. Am J Cardiol. 2023 08 15; 201:92-100.
    View in: PubMed
    Score: 0.018
  27. Revascularization Options for Left Main Disease: What Clinicians Need to Know. Curr Atheroscler Rep. 2023 06; 25(6):267-273.
    View in: PubMed
    Score: 0.018
  28. Clinical Outcomes of Transcatheter Aortic Valve Replacement (TAVR) Vs. Surgical Aortic Valve Replacement (SAVR) in Patients With Durable Left Ventricular Assist Device (LVAD). Curr Probl Cardiol. 2022 Oct; 47(10):101313.
    View in: PubMed
    Score: 0.017
  29. Routine Invasive Strategy in Elderly Patients with Non-ST Elevation Acute Coronary Syndrome: An Updated Systematic Review and Meta-analysis of Randomized Trials. Curr Probl Cardiol. 2022 Oct; 47(10):101304.
    View in: PubMed
    Score: 0.016
  30. Outcomes of MitraClip and Surgical Mitral Valve Repair in Patients With Left Ventricular Assist Device. Am J Cardiol. 2022 06 15; 173:143-145.
    View in: PubMed
    Score: 0.016
  31. Do We Really Need Aspirin Loading for STEMI? Cardiovasc Drugs Ther. 2022 12; 36(6):1221-1238.
    View in: PubMed
    Score: 0.016
  32. Cerebral Embolic Protection during Transcatheter Aortic Valve Implantation: Updated Systematic Review and Meta-Analysis. Curr Probl Cardiol. 2023 Jun; 48(6):101127.
    View in: PubMed
    Score: 0.016
  33. Outcomes of Transcatheter Aortic Valve Implantation in Patients With Chronic and End-Stage Kidney Disease. Am J Cardiol. 2022 02 01; 164:100-102.
    View in: PubMed
    Score: 0.016
  34. Trends and Outcomes of Ischemic Stroke after Transcatheter Aortic Valve Implantation, A US National Propensity Matched Analysis. Curr Probl Cardiol. 2022 Oct; 47(10):100961.
    View in: PubMed
    Score: 0.016
  35. Meta-analysis comparing valve-in-valve TAVR and redo-SAVR in patients with degenerated bioprosthetic aortic valve. Catheter Cardiovasc Interv. 2021 11 01; 98(5):940-947.
    View in: PubMed
    Score: 0.015
  36. Long-Term Outcomes Comparing Medical Therapy versus Revascularization for Spontaneous Coronary Artery Dissection. Am J Med. 2021 07; 134(7):e403-e408.
    View in: PubMed
    Score: 0.015
  37. Efficacy of Long-Term Oral Beta-Blocker Therapy in Patients Who Underwent Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction With Preserved Left Ventricular Ejection Fraction: A Systematic Review and Meta-analysis. J Cardiovasc Pharmacol. 2021 01 01; 77(1):87-93.
    View in: PubMed
    Score: 0.015
  38. Meta-Analysis Comparing Culprit-Only Versus Complete Multivessel Percutaneous Coronary Intervention in Patients With ST-Elevation Myocardial Infarction. Am J Cardiol. 2021 01 15; 139:34-39.
    View in: PubMed
    Score: 0.015
  39. Statin Prescription Rates, Adherence, and Associated Clinical Outcomes Among Women with PAD and ICVD. Cardiovasc Drugs Ther. 2020 12; 34(6):745-754.
    View in: PubMed
    Score: 0.015
  40. Inferior ST-Elevation Myocardial Infarction Presenting When Urgent Primary Percutaneous Coronary Intervention Is Unavailable: Should We Adhere to Current Guidelines? Cardiovasc Drugs Ther. 2020 12; 34(6):865-870.
    View in: PubMed
    Score: 0.014
  41. A Modern History RAAS Inhibition and Beta Blockade for Heart Failure to Underscore the Non-equivalency of ACEIs and ARBs. Cardiovasc Drugs Ther. 2020 04; 34(2):215-221.
    View in: PubMed
    Score: 0.014
  42. Pathophysiology, Diagnosis, and Management of the No-Reflow Phenomenon. Cardiovasc Drugs Ther. 2019 10; 33(5):589-597.
    View in: PubMed
    Score: 0.014
  43. Outcomes following percutaneous coronary intervention in patients with cancer. Int J Cardiol. 2020 02 01; 300:106-112.
    View in: PubMed
    Score: 0.014
  44. Association of Body Mass Index With Risk Factor Optimization and Guideline-Directed Medical Therapy in US Veterans With Cardiovascular Disease. Circ Cardiovasc Qual Outcomes. 2019 01; 12(1):e004817.
    View in: PubMed
    Score: 0.013
  45. Do We Need Potent Intravenous Antiplatelet Inhibition at the Time of Reperfusion During ST-Segment Elevation Myocardial Infarction? J Cardiovasc Pharmacol Ther. 2019 05; 24(3):215-224.
    View in: PubMed
    Score: 0.013
  46. SGLT2 Inhibitors and Cardiovascular Outcomes: Current Perspectives and Future Potentials. Curr Diab Rep. 2018 07 11; 18(9):63.
    View in: PubMed
    Score: 0.013
  47. Ticagrelor Use in Acute Myocardial Infarction: Insights From the National Cardiovascular Data Registry. J Am Heart Assoc. 2018 06 09; 7(12).
    View in: PubMed
    Score: 0.012
  48. GLP-1 Receptor Agonists and Cardiovascular Disease: a Meta-Analysis of Recent Cardiac Outcome Trials. Cardiovasc Drugs Ther. 2018 02; 32(1):65-72.
    View in: PubMed
    Score: 0.012
  49. Trends and Outcomes of Off-label Use of Transcatheter Aortic Valve Replacement: Insights From the NCDR STS/ACC TVT Registry. JAMA Cardiol. 2017 08 01; 2(8):846-854.
    View in: PubMed
    Score: 0.012
  50. Efficacy of Angiotensin-Converting Enzyme Inhibitors and Angiotensin-Receptor Blockers in Coronary Artery Disease without Heart Failure in the Modern Statin Era: a Meta-Analysis of Randomized-Controlled Trials. Cardiovasc Drugs Ther. 2016 Apr; 30(2):189-98.
    View in: PubMed
    Score: 0.011
  51. A case of biventricular failure after pericardial window for large pericardial effusion. Heart Surg Forum. 2015 Feb 27; 18(1):E36-7.
    View in: PubMed
    Score: 0.010
  52. Coronary artery disease performance measures and statin use in patients with recent percutaneous coronary intervention or recent coronary artery bypass grafting (from the NCDR PINNACLE registry). Am J Cardiol. 2015 Apr 15; 115(8):1013-8.
    View in: PubMed
    Score: 0.010
  53. Frequency and practice-level variation in inappropriate and nonrecommended prasugrel prescribing: insights from the NCDR PINNACLE registry. J Am Coll Cardiol. 2014 Jul 01; 63(25 Pt A):2876-7.
    View in: PubMed
    Score: 0.009
  54. Stellate ganglion block: a therapeutic alternative for patients with medically refractory inappropriate sinus tachycardia? J Electrocardiol. 2013 Nov-Dec; 46(6):693-6.
    View in: PubMed
    Score: 0.009
  55. Coronary artery bypass graft surgery remains the standard of care for patients with diabetes. Semin Thorac Cardiovasc Surg. 2013; 25(2):97-9.
    View in: PubMed
    Score: 0.009
  56. Association between statins and infections after coronary artery bypass grafting. Int J Cardiol. 2013 Sep 20; 168(1):117-20.
    View in: PubMed
    Score: 0.008
  57. Outcomes of preoperative angiotensin-converting enzyme inhibitor therapy in patients undergoing isolated coronary artery bypass grafting. Am J Cardiol. 2012 Oct 01; 110(7):919-23.
    View in: PubMed
    Score: 0.008
  58. An analysis of surgical shunts for the management of portal hypertension at Aga Khan University Hospital. J Ayub Med Coll Abbottabad. 2004 Oct-Dec; 16(4):70-4.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.